Danavish Trimetazidine 35mg Tablet MR
Prescription Required
Product introduction
Danavish Trimetazidine 35mg Tablet MR is an anti-anginal medicine used for treating heart-related chest pain (angina). It prevents new attacks of angina but does not stop an acute attack once it has started. It can be used alone or in combination with some other medicines.
Danavish Trimetazidine 35mg Tablet MR is a medicine used for treating heart-related chest pain (angina) caused due to narrowing of blood vessels of the heart. It effectively prevents new attacks of angina but does not stop an acute attack once it has started. This medicine should be used along with lifestyle changes like healthy diet, regular exercise, and smoking cessation for best results. It is used as an add-on therapy for patients who are not relieved by or are intolerant to the initial medicines. It should not be stopped abruptly. Headache, vomiting, and dizziness may be seen as side effects.
Danavish Trimetazidine 35mg Tablet MR is a medicine used for treating heart-related chest pain (angina) caused due to narrowing of blood vessels of the heart. It effectively prevents new attacks of angina but does not stop an acute attack once it has started. This medicine should be used along with lifestyle changes like healthy diet, regular exercise, and smoking cessation for best results. It is used as an add-on therapy for patients who are not relieved by or are intolerant to the initial medicines. It should not be stopped abruptly. Headache, vomiting, and dizziness may be seen as side effects.
Uses of Danavish Tablet MR
Benefits of Danavish Tablet MR
In Treatment of Angina (heart-related chest pain)
Angina is chest pain or discomfort that happens when there is not enough oxygen-rich blood going to part of your heart. This can occur when the blood vessels of the heart become narrow. By preserving energy metabolism in cells exposed to reduced oxygen supply, Danavish Trimetazidine 35mg Tablet MR prevents a decrease in intracellular energy levels, thereby ensuring the proper functioning of heart muscle cells. Danavish Trimetazidine 35mg Tablet MR can also help increase your ability to exercise and lead your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.
Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with Danavish Trimetazidine 35mg Tablet MR.
Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with Danavish Trimetazidine 35mg Tablet MR.
Side effects of Danavish Tablet MR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Danavish
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Danavish Tablet MR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Danavish Trimetazidine 35mg Tablet MR is to be taken with food.
How Danavish Tablet MR works
Danavish Trimetazidine 35mg Tablet MR is an anti-anginal medication. It decreases the oxygen requirement of the heart by shifting its metabolism from fats to glucose. As a result, the heart works more efficiently.
Safety advice
Alcohol
UNSAFE
Danavish Trimetazidine 35mg Tablet MR may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Danavish Trimetazidine 35mg Tablet MR during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Danavish Trimetazidine 35mg Tablet MR during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
Danavish Trimetazidine 35mg Tablet MR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Danavish Trimetazidine 35mg Tablet MR should be used with caution in patients with kidney disease. Dose adjustment of Danavish Trimetazidine 35mg Tablet MR may be needed. Please consult your doctor.
Use of Danavish Trimetazidine 35mg Tablet MR is not recommended in patients with severe kidney disease.
Use of Danavish Trimetazidine 35mg Tablet MR is not recommended in patients with severe kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Danavish Trimetazidine 35mg Tablet MR in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Danavish Trimetazidine 35mg Tablet MR
₹6.0/Tablet MR
Flavedon MR Tablet
Serdia Pharmaceuticals India Pvt Ltd
₹13.09/tablet mr
138% costlier
Carvidon -MR Tablet
Micro Labs Ltd
₹15.5/tablet mr
182% costlier
Trivedon MR Tablet
Cipla Ltd
₹17.1/tablet mr
211% costlier
FLAVMOX 35MG TABLET MR
Maxlive Pharmaceuticals Pvt Ltd
₹9.2/tablet mr
67% costlier
Trimezen 35mg Tablet MR
Elder Pharmaceuticals Ltd
₹8/tablet mr
45% costlier
Quick tips
- Danavish Trimetazidine 35mg Tablet MR prevents new attacks of angina but does not stop an acute attack.
- Does not affect heart rate, blood pressure at rest or during exercise.
- Improves HbA1c and blood sugar levels in diabetes patients.
- Avoid driving or using machinery if you feel dizzy after taking Danavish Trimetazidine 35mg Tablet MR.
Fact Box
Chemical Class
Phenylmethylamines
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Fatty acid modulator & Sodium channel blocker
Patient concerns
FAQs
Is Danavish Trimetazidine 35mg Tablet MR a beta blocker?
No, Danavish Trimetazidine 35mg Tablet MR is not a beta blocker. It is an anti-anginal medicine which is used in combination with other medicines to treat angina pectoris (chest pain caused by coronary disease). It protects the heart cells from getting affected by the reduced oxygen supply during an episode of angina.
Who should not take Danavish Trimetazidine 35mg Tablet MR?
You should not take Danavish Trimetazidine 35mg Tablet MR if you are allergic to it or have severe kidney problems. Patients with Parkinson’s disease should also avoid taking Danavish Trimetazidine 35mg Tablet MR. Parkinson’s disease is a disease of the brain which affects movement and causes trembling, rigid posture, slow movements and a shuffling, unbalanced walk.
Can Danavish Trimetazidine 35mg Tablet MR be used in elderly patients?
Danavish Trimetazidine 35mg Tablet MR should be used with caution in patients aged more than 75 years of age. Usually, a lower dose is prescribed in elderly patients to reduce the chances of adverse effects. It is important to continuously monitor such patients.
Does taking Danavish Trimetazidine 35mg Tablet MR increases the risk of falling down frequently?
Though it is rare, falls may occur with use of Danavish Trimetazidine 35mg Tablet MR. This may be due to instability while walking or fall in blood pressure while standing up. The risk may be higher in elderly patients. Therefore, they need to be more careful and should be monitored.
Does Danavish Trimetazidine 35mg Tablet MR cause drowsiness?
Yes, Danavish Trimetazidine 35mg Tablet MR may make you feel dizzy and drowsy. Therefore, you should avoid driving or using heavy machinery in case it causes these side effects.
How should Danavish Trimetazidine 35mg Tablet MR be taken?
You should take Danavish Trimetazidine 35mg Tablet MR exactly as prescribed by your doctor. It is meant for oral use. So, take the tablets with sufficient amount of liquid, e.g. a glass of water. You can take this medicine with or without food.
What are the possible side effects of Danavish Trimetazidine 35mg Tablet MR?
The common side effects of Danavish Trimetazidine 35mg Tablet MR include dizziness, headache, abdominal pain, diarrhea, indigestion, and hives, rash and itching. Its use may also make you feel sick and weak. The rare side effects may include fast or irregular heartbeats (also called palpitations), fall in blood pressure on standing which can further cause dizziness, lightheadedness or fainting, fall, and flushing.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Trimetazidine dihydrochloride. Suresnes Cedex, France: Les Laboratoires Servier; 2001 [revised 27 Mar. 2007]. [Accessed 20 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
- CiplaMed. Trimetazidine dihydrochloride [Prescribing Information]. [Accessed 07 Aug. 2023]. (online) Available from:
- Trimetazidine dihydrochloride [Package leaflet: Information for the user]. Gidy, France: Les Laboratoires Servier Industrie; 2021. [Accessed 07 Aug. 2023]. (online) Available from:
- Ciapponi A, Pizarro R, Harrison J. WITHDRAWN: Trimetazidine for stable angina. Cochrane Database Syst Rev. 2017 Mar 20;3(3):CD003614. [Accessed 07 Aug. 2023]. (online) Available from:
Marketer details
Name: Danavish Healthcare
Address: Vetturnimadam Nagercoil ,Tamil Nadu
Country of origin: India
Lab tests offered by us
Related/Popular tests
194 people viewed this recentlyMRP
₹60
Inclusive of all taxes
10.0 tablet mr in 1 strip
SOLD OUT